Celanese Corp: Form 10-Q for the period ended Mar 31, 2019
Filed with the SEC on Apr 23, 2019 and accepted by EDGAR at Apr 23, 2019, 16:19 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-01-01 to 2019-03-31 | $1.69bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2019-01-01 to 2019-03-31 | $1.23bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2019-01-01 to 2019-03-31 | $453.0m | us-gaap:GrossProfit |
| Research and development | 3 months2019-01-01 to 2019-03-31 | $16.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2019-01-01 to 2019-03-31 | $120.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2019-01-01 to 2019-03-31 | $320.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2019-01-01 to 2019-03-31 | $31.0m | us-gaap:InterestExpense |
| Income tax | 3 months2019-01-01 to 2019-03-31 | $46.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-01-01 to 2019-03-31 | $337.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-01-01 to 2019-03-31 | $2.63 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-01-01 to 2019-03-31 | $2.64 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-01-01 to 2019-03-31 | 128,215,700 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2019-01-01 to 2019-03-31 | $307.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2019-01-01 to 2019-03-31 | $79.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2019-01-01 to 2019-03-31 | $70.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2019-01-01 to 2019-03-31 | $212.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-03-31 | $441.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-03-31 | $2.88bn | us-gaap:AssetsCurrent |
| Total assets | At period end2019-03-31 | $9.57bn | us-gaap:Assets |
| Current liabilities | At period end2019-03-31 | $1.82bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2019-03-31 | $2.93bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2019-03-31 | $743.0m | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2019-03-31 | $3.05bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001306830-19-000092. Last ingested by Listed: Nov 13, 2026, 16:24 ET. Listed shows no prices and gives no investment advice.